Evidence-first workflow
Organize PubMed, ClinVar, scientific context, ACMG draft logic, and review notes into traceable evidence cards.
Trust & Safety
Human-review-first clinical genomic AI.
Tynixa is designed around review-ready assistance, audit traceability, PHI boundaries, and qualified human review rather than autonomous clinical decisions.
Human-review-first
Tynixa creates review-ready drafts only. It does not issue autonomous final diagnosis, treatment, or ACMG classification.
Built for conversion
Each page routes visitors toward Start Trial, Book Demo, Ask Tynixa, or Request Pilot with local analytics tracking.
Clinical safety boundary
Tynixa supports clinical interpretation workflows but requires qualified human review and sign-off. Trial workspaces use demo or synthetic cases only and do not allow production PHI.